Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹552.31 Cr
Market Cap
Total market value of companyP/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
2.48
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹-9.17
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-2.95%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
3.32%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-3.99%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
10.33%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
19.60%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
183.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.22
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹264.55
Book Value
Net asset value per shareDividend Yield
0.52%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
72.20%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •Promoter holding is robust at 72.18% as of September 2025, indicating strong confidence from the core management in the company's long-term prospects and stability. This high stake aligns management and shareholder interests.
- •The company maintains a healthy debt-to-equity ratio of 0.22, suggesting a conservative financial structure and lower reliance on borrowed capital, which reduces financial risk and enhances stability.
Weaknesses
5 points- •With a P/E ratio of 316.00, significantly above the sector P/E of 256.82 and peers, the stock appears highly overvalued, posing a risk of correction if earnings do not justify this premium.
- •The company reported a negative EPS of -3.68, coupled with very low Return on Equity (ROE) of 2.33% and Return on Capital Employed (ROCE) of 3.32%, indicating poor overall profitability.
Opportunities
3 points- •As a player in the Commodity Chemicals industry, Chemfab Alkalis can capitalize on the broader sector growth (sector PE 256.82), driven by increasing industrial demand and economic expansion.
- •Given its relatively small market cap of 871 Cr compared to larger peers, the company has significant room to expand its market share through strategic initiatives and product diversification.
Threats
4 points- •The company faces stiff competition from larger, more profitable peers like SRF (ROCE 12.27%) and Deepak Fertilisers (ROCE 15.67%), potentially limiting its growth and pricing power in the market.
- •As a commodity chemicals producer, the company is highly susceptible to fluctuations in raw material prices, which can significantly impact its operating margins and overall profitability.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
Recent Insider Transactions
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
VAITHAMANITHI MUDUMBAI SRINIVASAN | 31 Jan 2025 | 05 Feb 2025 | 2.60 L | 35,500 | ₹97.83 | BUY |
S Prasath | 30 Jan 2025 | 05 Feb 2025 | 40,100 | 14,000 | ₹97.83 | BUY |
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹420.78 | +₹47.23 | +12.64% |
| R3 | ₹401.38 | +₹27.83 | +7.45% |
| R2 | ₹390.42 | +₹16.87 | +4.52% |
| R1 | ₹381.98 | +₹8.43 | +2.26% |
| PIVOT | ₹371.02 | -2.53 | -0.68% |
| CURRENT | ₹373.55 | - | - |
| S1 | ₹323.78 | -₹49.77 | -13.32% |
| S2 | ₹343.18 | -₹30.37 | -8.13% |
| S3 | ₹351.62 | -₹21.93 | -5.87% |
| S4 | ₹362.58 | -₹10.97 | -2.94% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-9.1% vs avg
0.07L
(02 Mar 2026)Delivery %-17.9% vs avg
33.4%
(02 Mar 2026)Avg Volume (20D)20-day average
0.08L
(03 Feb - 02 Mar)Avg Delivery %Trend ↓
51.3%
(03 Feb - 02 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Solar Industries India Ltd
1.20L ₹ Cr
Best Profit Growth
OCCL Ltd
32950.00 %
Highest Dividend Yield
Rubfila International Ltd
2.88 %
Peer Comparison
| Company Name |
|---|
 Andhra Sugars Ltd |
 Bodal Chemicals Ltd |
 Indo Borax & Chemicals Ltd |
 Kothari Petrochemicals Ltd |
 Nahar Polyfilms Ltd |
 OCCL Ltd |
 Rubfila International Ltd |
 Solar Industries India Ltd |
 Sree Rayalaseema Hi-Strength Hypo Ltd |
 Valiant Organics Ltd |
About
Chemfab Alkalis Ltd
Chemfab Alkalis Limited, along with its subsidiary Chemfab Alkalis Karaikal Limited, is a prominent Indian manufacturer and seller of inorganic chemicals with an international presence. Their primary business operations are divided into two segments: Chemicals and Related Products/Services, and PVC-O Pipes.
The Chemicals and Related Products/Services segment forms the core of Chemfab's business. This segment focuses on the production and distribution of a wide range of inorganic chemicals. Key products include caustic soda (in lye and flake forms), liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite (bleach liquor). Beyond these core offerings, they also manufacture sodium chlorate, aluminum chloride, and a diverse portfolio of other chemicals such as alkalis, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes, ketones, amines, alkaloids, potassium chlorate, and perchlorate, along with their by-products and derivatives. This breadth of offerings caters to a variety of industrial applications.
In addition to their extensive chemical portfolio, Chemfab Alkalis also operates in the PVC-O Pipes segment. This segment focuses on the manufacturing and sales of PVC-O (polyvinyl chloride-oriented) pipes, likely for industrial or commercial applications, though the specifics of target markets aren't provided in the source data. The company also produces industrial-grade and edible salt products, further diversifying its product offerings.
Founded in 1985 and initially known as Teamec Chlorates Limited, the company rebranded to Chemfab Alkalis Limited in July 2017. Headquartered in Chennai, India, Chemfab Alkalis has established itself as a significant player in the Indian and international inorganic chemical markets, leveraging its diverse product portfolio and manufacturing capabilities.
COMPANY FACTS - CHEMFAB
Registered Address
2VG6+H32, Gnanananda Place, E Coast Main Rd, Kalapet, Chinna Kalapet
Puducherry
PONDICHERRY
IN
Tel: 914132655111
Website:https://chemfabalkalis.com/
Investor Relations:https://chemfabalkalis.com/investors/
Company Details
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 210
IPO Date: 25/04/2018
MANAGEMENT - CHEMFAB
Mr. V. M. Srinivasan
Chief Executive Officer
Mr. Suresh Rao
Non-Executive Chairman of the Board
Mr. S. Prasath
Chief Financial Officer
Mr. Bharatraj Panchal
Compliance Officer, Company Secretary
Mr. Nitin Cowlagi
Non-Executive Director
Mr. R. Mahendran
Non-Executive Director
Mrs. Drushti Desai
Non-Executive Independent Director
Mr. Satish Jajoo
Additional Non-Executive Independent Director
Mr. Ananthanarayanan Janakiraman
Non-Executive Independent Director
Mrs. Sujatha Jayarajan
Non-Executive Independent Director
Investor Questions Answered
Chemfab Alkalis Ltd (CHEMFAB) Stock FAQs
Get answers to the most common questions about Chemfab Alkalis Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Chemfab Alkalis Ltd (CHEMFAB) is ₹373.55. Today, the stock has declined by ₹5.95 (1.57%), trading in a range of ₹360.05 to ₹379.45. The stock opened at ₹373.8 with a trading volume of 7,015 shares.
Chemfab Alkalis Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹552.31 crores, P/E ratio of 0.00, ROE of -2.95%, and ROCE of 3.32%. The dividend yield stands at 0.52%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Chemfab Alkalis Ltd (CHEMFAB) is ₹905.55, while the 52-week low is ₹371.55. Currently trading at ₹373.55, the stock is 0.4% away from its 52-week low and 58.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Chemfab Alkalis Ltd stock at ₹373.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a loss of 1.57%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Chemfab Alkalis Ltd offers a dividend yield of 0.52%, which means for every ₹100 invested at the current price of ₹373.55, you can expect to receive approximately ₹0.52 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Chemfab Alkalis Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: -2.95%, ROCE: 3.32%, Dividend Yield: 0.52%, EPS: ₹-9.17, Book Value: ₹264.55, Debt-to-Equity: 0.22, and Current Ratio: N/A. The company's market cap stands at ₹552.31 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Chemfab Alkalis Ltd stock opened at ₹373.8 and is currently trading at ₹373.55, showing a decline of ₹5.95 (1.57%). The intraday high is ₹379.45 and low is ₹360.05. The trading volume stands at 7,015 shares, indicating moderate market participation today.
Chemfab Alkalis Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-9.17, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
Chemfab Alkalis Ltd has a market capitalization of ₹552.31 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹373.55) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Chemfab Alkalis Ltd has a book value of ₹264.55 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹373.55, which is 41.2% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Chemfab Alkalis Ltd has a Return on Equity (ROE) of -2.95% and Return on Capital Employed (ROCE) of 3.32%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Chemfab Alkalis Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Chemfab Alkalis Ltd has a debt-to-equity ratio of 0.22, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Chemfab Alkalis Ltd has an Earnings Per Share (EPS) of ₹-9.17, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹373.55 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Chemfab Alkalis Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Chemfab Alkalis Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Chemfab Alkalis Ltd stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (-2.95%), debt-to-equity (0.22), and growth rates. 2) Technical Analysis - Check 52-week range (₹371.55 - ₹905.55), moving averages, and chart patterns. 3) Valuation - Compare current price (₹373.55) with book value (₹264.55) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Chemfab Alkalis Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹373.55 is 3636x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Chemfab Alkalis Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹371.55 - ₹905.55). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.22 indicates leverage. 4) Liquidity Risk - Based on trading volume of 7,015 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Chemfab Alkalis Ltd operates in the industry with key metrics: P/E ratio of 0.00, ROE of -2.95%, market cap of ₹552.31 crores, and dividend yield of 0.52%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.22), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Chemfab Alkalis Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹373.55, with a 52-week range of ₹371.55 to ₹905.55. Based on fundamentals like P/E (0.00), ROE (-2.95%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Chemfab Alkalis Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹373.55. 2) Fundamental Deterioration - Declining ROE (currently -2.95%), increasing debt (D/E: 0.22), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Chemfab Alkalis Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.52%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu